Chmielewska B, Hasiec T, Belniak-Legieć E
Katedra i Klinika Neurologii Akademii Medycznej w Lublinie.
Ann Univ Mariae Curie Sklodowska Med. 1996;51:61-8.
Fasting blood glucose level, glycosylated haemoglobin (HBA1) and fructosamine (FA) were measured in 37 non-diabetic patients with a recent (48 h) brain infarction of the carotid territory. The severity of hemiparesis was assessed on admission, and in the 2nd week and 1st month. The functional outcome and fatality rate was estimated after 1 month. On the basis of elevated the HBA1 concentration the group of 54% patients was diagnosed to have prestroke hyperglycemia. Hyperglycemia predating cerebral infarction did not influence fasting glycemia during the few days after stroke. Fasting blood glucose concentration but not the preceding 2-3 months and 2-3 weeks glycemia correlated strongly with the severity of hemiparesis and predicted stroke outcome. Measurement of HBA1 seems to be useful as a screening test for mild, clinically silent diabetes in patients without other risk factors for cerebral stroke.
对37例近期(48小时内)发生颈动脉供血区脑梗死的非糖尿病患者测定了空腹血糖水平、糖化血红蛋白(HBA1)和果糖胺(FA)。入院时、第2周和第1个月评估偏瘫的严重程度。1个月后评估功能结局和死亡率。根据HBA1浓度升高,54%的患者被诊断为卒中前高血糖。脑梗死后数天内,脑梗前的高血糖并未影响空腹血糖水平。空腹血糖浓度与偏瘫严重程度密切相关,可预测卒中结局,而前2 - 3个月及2 - 3周的血糖水平则不然。对于没有其他脑卒中危险因素的患者,测定HBA1似乎是筛查轻度临床无症状糖尿病的有用方法。